Acetylcholine Chloride NDC 43742-0817

NDC codes

FDA NDC Directory

Product NDC (as listed)43742-0817Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43742-0817Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43742-0817-1	43742081701	30 mL in 1 BOTTLE, DROPPER (43742-0817-1)Marketed from Jul 21, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acetylcholine Chloride
Generic name (nonproprietary): acetylcholine chloride
Active ingredients: Acetylcholine chloride — 6 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Deseret Biologicals, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 21, 2016
Marketing end: Sep 15, 2028
Other FDA classes: Cholinergic Agonists (Mechanism)
Identifiers: Product ID 43742-0817_622cbf1c-9142-4f30-96d7-da05d751da11SPL ID 622cbf1c-9142-4f30-96d7-da05d751da11SPL set ID 62fd8726-8be8-4d32-a11e-85c02ef368c8UNII AF73293C2R
Pharmacologic class: Cholinergic Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443742081701 followed by a unit qualifier and the quantity

Package 43742-0817-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2024.

Indications (excerpt from the label)

INDICATIONS: For temporary relief of symptoms including dizziness, chest congestion, cough, fatigue, rash, itching, headache and poor memory.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)